Sex differences in pharmacokinetics and pharmacodynamics

Area of Science:

• Pharmacology
• Pharmacogenomics
• Clinical Pharmacy

Background:

• Growing evidence highlights significant gender variations in drug efficacy and toxicity.
• Interindividual pharmacokinetic variability is influenced by sex-based differences in bioavailability, distribution, metabolism, and elimination.
• Sex-based variations in pharmacodynamics are increasingly recognized but historically challenging to study.

Purpose of the Study:

• To review the biological basis of sex differences in pharmacokinetics and pharmacodynamics.
• To summarize existing research on sex-based variations in drug response.
• To illustrate these differences using antiretroviral therapy in HIV-infected patients.

Main Methods:

• Literature review of studies investigating sex-based differences in drug parameters.
• Analysis of factors contributing to pharmacokinetic variability (e.g., body weight, metabolism, excretion).
• Examination of pharmacodynamic variations and their clinical implications.

Main Results:

• Sex influences key pharmacokinetic processes: absorption, distribution, metabolism, and excretion.
• Factors like body composition, hormonal status, and enzyme activity contribute to sex-based drug response differences.
• Antiretroviral therapy efficacy and toxicity can vary significantly between sexes.

Conclusions:

• Acknowledging and studying sex-based differences is essential for optimizing drug therapy.
• Understanding these variations can lead to personalized medicine approaches.
• Further research is needed to fully elucidate and address sex-based drug response disparities.